NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Pacira Pharmaceuticals, Inc. 

10450 Science Center Drive

San Diego  California  92121  U.S.A.
Phone: 858-625-2414 Fax: 858-678-3999


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Pacira Pharmaceuticals, Inc.'s Phase III Study of EXPAREL(TM) Meets Primary Pain Relief Endpoint 10/20/2009 6:35:58 AM    More...
Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Pharmaceuticals, Inc. Complete Enrollment Data from Soft Tissue and Bone Surgery Studies Basis of Planned 2009 NDA Filing 1/6/2009 8:11:34 AM    More...
Pacira Pharmaceuticals, Inc. Positive Phase II Study of Pacira's EXPAREL(TM) (DepoBupivacaine) in Hernia Repair Presented at the Postgraduate Assembly in Anesthesiology (PGA) Novel Local Analgesic Results in Sustained Plasma Concentrations Significantly Reducing Postoperative Pain 12/15/2008 8:02:40 AM    More...
Pacira Pharmaceuticals, Inc. Adds Experienced Physician Dr. David St. Peter to Leadership Team 10/2/2008 8:04:55 AM    More...
Pacira Pharmaceuticals, Inc. Adds Experienced CFO James S. Scibetta to Leadership of the Organization 8/6/2008 7:43:47 AM    More...
Pacira Pharmaceuticals, Inc. Adds Board Member and Key Senior Management 7/9/2008 9:12:14 AM    More...
Pacira Pharmaceuticals, Inc. Expands Development Collaborations for DepoFoam(R) 4/15/2008 7:59:21 AM    More...
Pacira Pharmaceuticals, Inc. Names New CEO and President 12/19/2007 7:25:37 AM    More...
Orphan Australia Pty Ltd Receives Registration Approval for the New Dose Form DepoDur(R), Pacira Pharmaceuticals, Inc.'s Modified Release Injection of Morphine Sulfate 10/22/2007 10:20:57 AM    More...
Flynn Pharma Acquires Rights From Pacira Pharmaceuticals, Inc. to DepoDur(R), the Only Extended-Release Epidural Opioid for Post-Operative Pain, in Europe 9/27/2007 12:38:48 PM    More...
12